Search our database and find Biotech companies in Belarus based on your preferred criteria. Get key company details, track changes, and gain actionable insights to drive business growth or investment decisions.
Get to know our data at a glance with this sample company profile. We cover everything you need to know about Belarus Biotech companies.
Available data points
Metadata
company_id
9463230
source_id
2110795
unique_domain
1
unique_website
1
last_updated_at
2025-04-03
created_at
2016-06-25
description
Who we are Formycon is a leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars. The company focuses on treatments in ophthalmology, immunology and on other key chronic diseases, covering the entire value chain from technical development to the clinical phase III as well as the preparation of dossiers for marketing approval. With its biosimilars, Formycon is making a major contribution towards providing as many patients as possible with access to vital and affordable medicines. Formycon currently has four biosimilars in development. Based on its extensive experience in the development of biopharmaceutical drugs, the company is also working on the development of a COVID-19 drug FYB207 About Biosimilars: Since their introduction in the 1980s, biopharmaceuticals have revolutionized the treatment of serious diseases such as cancer, diabetes, rheumatoid arthritis, multiple sclerosis and eye diseases. In the coming years, many of these biotech drugs will lose their patent protection – and by 2020, medications with revenues of approximately USD 100 billion will be off patent. Biosimilars are follow-on versions of biopharmaceuticals, for which exclusivity has expired. They are approved via stringent regulatory pathways in highly regulated markets (such as EU, US, Japan, Canada, Australia) based on proven similarity of the biosimilar with the originator biopharmaceutical reference product. Global sales of biosimilars are estimated to exceed $15 billion by 2020. By 2030, analysts estimate that this figure could rise to over $60 billion. Contact: Formycon AG Fraunhoferstr. 15 82152 Martinsried/Planegg Germany phone +49 (0) 89 - 86 46 67 100 fax + 49 (0) 89 - 86 46 67 110 [email protected]
type
Public Company
industry_group_1
Biotech
Firmographics
company_name
Formycon AG
is_b2b
1
industry
Biotechnology Research
founded_year
2012
size_range
201-500 employees
employees_count
192
Locations
hq_country
Belarus
hq_country_iso2
BY
hq_country_iso3
BLR
hq_location
Planegg, BY, Belarus
hq_full_address
*******
Follower counts & changes
followers_count_professional_network
7789
followers_count_owler
8
Financials
is_public
1
ipo_date
2010-12-20
Funding
last_funding_round_name
Post-IPO Equity - Formycon
last_funding_round_announced_date
2024-01-29
last_funding_round_amount_raised
89752563
last_funding_round_amount_raised_currency
$
last_funding_round_num_investors
1
Technographics
num_technologies_used
16
Company websites and social media
website
https://www.formycon.com
professional_network_url
https://www.professional-network.com/company/formycon
financial_website_url
https://www.financial-website.com/organization/formycon
Website traffic
total_website_visits_monthly
17100
visits_change_monthly
15.13
rank_global
1241796
rank_country
156295
rank_category
172
bounce_rate
33.94
pages_per_visit
2.97
average_visit_duration_seconds
191
Employee review score & changes
company_employee_reviews_count
7
company_employee_reviews_aggregate_score
4
Workforce trends
active_job_postings_count
2
JSON data sample
{ "company_id": 9463230, "source_id": "2110795", "company_name": "Formycon AG", "company_name_alias": [ "formycon ag", "formycon" ], "company_legal_name": null, "company_logo": "/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAMCAgMCAgMDAwMEAwMEBQgFBQQEBQoHBwYIDAoMDAsK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\r\niuQ2CiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA//9k=", "website": "https://www.formycon.com", "professional_network_url": "https://www.professional-network.com/company/formycon", "twitter_url": [], "discord_url": [], "facebook_url": [], "instagram_url": [], "pinterest_url": [], "tiktok_url": [], "youtube_url": [], "github_url": [], "reddit_url": [], "financial_website_url": "https://www.financial-website.com/organization/formycon", "stock_ticker": [ { "exchange": null, "ticker": "FYB.F" }, { "exchange": "FRA", "ticker": "FYB" } ], "is_b2b": 1, "industry": "Biotechnology Research", "sic_codes": [ "28", "283" ], "naics_codes": [ "32", "325" ], "categories_and_keywords": [ "pharmaceuticals", "health > biotechnology and pharmaceuticals (in germany)", "ophthalmology", "immunology", "scientific professionals", "biosimilar medicines", "drug product", "cmc with strong analytics", "device development", "preclinical & bioanalytics", "cmc regulatory affairs", "project management", "quality management", "certified gmp analytical laboratory", "biosimilar development", "anti body based covid-19 drugs", "biosimilars", "chronic diseases", "biopharmaceutical", "health", "pharma", "biopharma" ], "description": "Who we are Formycon is a leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars. The company focuses on treatments in ophthalmology, immunology and on other key chronic diseases, covering the entire value chain from technical development to the clinical phase III as well as the preparation of dossiers for marketing approval. With its biosimilars, Formycon is making a major contribution towards providing as many patients as possible with access to vital and affordable medicines. Formycon currently has four biosimilars in development. Based on its extensive experience in the development of biopharmaceutical drugs, the company is also working on the development of a COVID-19 drug FYB207 About Biosimilars: Since their introduction in the 1980s, biopharmaceuticals have revolutionized the treatment of serious diseases such as cancer, diabetes, rheumatoid arthritis, multiple sclerosis and eye diseases. In the coming years, many of these biotech drugs will lose their patent protection – and by 2020, medications with revenues of approximately USD 100 billion will be off patent. Biosimilars are follow-on versions of biopharmaceuticals, for which exclusivity has expired. They are approved via stringent regulatory pathways in highly regulated markets (such as EU, US, Japan, Canada, Australia) based on proven similarity of the biosimilar with the originator biopharmaceutical reference product. Global sales of biosimilars are estimated to exceed $15 billion by 2020. By 2030, analysts estimate that this figure could rise to over $60 billion. Contact: Formycon AG Fraunhoferstr. 15 82152 Martinsried/Planegg Germany phone +49 (0) 89 - 86 46 67 100 fax + 49 (0) 89 - 86 46 67 110 [email protected]", "description_enriched": "Formycon AG is a leading and independent developer of high-quality biopharmaceutical replacement products, called Biosimilars.", "description_metadata_raw": null, "type": "Public Company", "status": { "value": "active", "comment": "Independent Company" }, "founded_year": "2012", "size_range": "201-500 employees", "employees_count": 192, "followers_count_professional_network": 7789, "followers_count_twitter": null, "followers_count_owler": 8, "hq_region": [ "Europe", "Eastern Europe", "EMEA" ], "hq_country": "Belarus", "hq_country_iso2": "BY", "hq_country_iso3": "BLR", "hq_location": "Planegg, BY, Belarus", "hq_full_address": "*******", "hq_city": null, "hq_state": null, "hq_street": null, "hq_zipcode": null, "company_locations_full": [ { "location_address": "*******", "is_primary": 1 }, { "location_address": "*******", "is_primary": 0 }, { "location_address": "*******", "is_primary": 0 }, { "location_address": "*******", "is_primary": 0 }, { "location_address": "*******", "is_primary": 0 } ], "is_public": 1, "ipo_date": "2010-12-20", "ipo_share_price": null, "ipo_share_price_currency": null, "revenue_annual_range": { "source_4_annual_revenue_range": null, "source_6_annual_revenue_range": { "annual_revenue_range_from": 50000000, "annual_revenue_range_to": 75000000, "annual_revenue_range_currency": "$" } }, "revenue_annual": { "source_5_annual_revenue": { "annual_revenue": 81466790, "annual_revenue_currency": "$" }, "source_1_annual_revenue": { "annual_revenue": 77696000, "annual_revenue_currency": "€" } }, "revenue_quarterly": null, "income_statements": [ { "cost_of_goods_sold": 11203000, "cost_of_goods_sold_currency": "€", "ebit": 8205000, "ebitda": 8610000, "ebitda_margin": 0.35012809564474806, "ebit_margin": 0.3336586556057094, "earnings_per_share": null, "gross_profit": 13454000, "gross_profit_margin": 0.54711073156846, "income_tax_expense": 620000, "interest_expense": 17000, "interest_income": 1000, "net_income": 7589000, "period_display_end_date": "H1, 2018", "period_end_date": "2018-06-30", "period_type": "h1", "pre_tax_profit": 8209000, "revenue": 24591000, "total_operating_expense": 4844000 }, { "cost_of_goods_sold": 24268000, "cost_of_goods_sold_currency": "€", "ebit": 7120000, "ebitda": 8024000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": 18839000, "gross_profit_margin": null, "income_tax_expense": 0, "interest_expense": 33000, "interest_income": 5000, "net_income": 7099000, "period_display_end_date": "FY, 2018", "period_end_date": "2018-12-31", "period_type": "fiscal_year", "pre_tax_profit": 7099000, "revenue": 42994000, "total_operating_expense": 10815000 }, { "cost_of_goods_sold": 12158000, "cost_of_goods_sold_currency": "€", "ebit": -692000, "ebitda": -243000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": 5721000, "gross_profit_margin": null, "income_tax_expense": 0, "interest_expense": 14000, "interest_income": 1000, "net_income": -695000, "period_display_end_date": "H1, 2019", "period_end_date": "2019-06-30", "period_type": "h1", "pre_tax_profit": -695000, "revenue": 17228000, "total_operating_expense": 5964000 }, { "cost_of_goods_sold": 22188000, "cost_of_goods_sold_currency": "€", "ebit": -2271000, "ebitda": -1359000, "ebitda_margin": -0.04098682027927738, "ebit_margin": -0.06849232439605513, "earnings_per_share": null, "gross_profit": 11672000, "gross_profit_margin": 0.35202219742437496, "income_tax_expense": -6000, "interest_expense": 28000, "interest_income": 3000, "net_income": -2293000, "period_display_end_date": "FY, 2019", "period_end_date": "2019-12-31", "period_type": "fiscal_year", "pre_tax_profit": -2299000, "revenue": 33157000, "total_operating_expense": 13031000 }, { "cost_of_goods_sold": 10777000, "cost_of_goods_sold_currency": "€", "ebit": -1333000, "ebitda": -885000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": 5759000, "gross_profit_margin": null, "income_tax_expense": 1000, "interest_expense": 29000, "interest_income": 1000, "net_income": -1382000, "period_display_end_date": "H1, 2020", "period_end_date": "2020-06-30", "period_type": "h1", "pre_tax_profit": -1381000, "revenue": 16509000, "total_operating_expense": 6644000 }, { "cost_of_goods_sold": 25466000, "cost_of_goods_sold_currency": "€", "ebit": -5738000, "ebitda": -4823000, "ebitda_margin": -0.1409121453823005, "ebit_margin": -0.16764542612557337, "earnings_per_share": null, "gross_profit": 9107000, "gross_profit_margin": 0.2660764893212961, "income_tax_expense": 93000, "interest_expense": 106000, "interest_income": 2000, "net_income": -5926000, "period_display_end_date": "FY, 2020", "period_end_date": "2020-12-31", "period_type": "fiscal_year", "pre_tax_profit": -5833000, "revenue": 34227000, "total_operating_expense": 13930000 }, { "cost_of_goods_sold": 21757000, "cost_of_goods_sold_currency": "€", "ebit": -10053000, "ebitda": -9599000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": -1336000, "gross_profit_margin": null, "income_tax_expense": 1000, "interest_expense": 80000, "interest_income": 1000, "net_income": -10170000, "period_display_end_date": "H1, 2021", "period_end_date": "2021-06-30", "period_type": "h1", "pre_tax_profit": -10169000, "revenue": 20309000, "total_operating_expense": 8263000 }, { "cost_of_goods_sold": 35959000, "cost_of_goods_sold_currency": "€", "ebit": -13300000, "ebitda": -12357000, "ebitda_margin": -0.3342891924793724, "ebit_margin": -0.3597998106316786, "earnings_per_share": null, "gross_profit": 5692000, "gross_profit_margin": 0.15398349790342217, "income_tax_expense": -24000, "interest_expense": 165000, "interest_income": 2000, "net_income": -13476000, "period_display_end_date": "FY, 2021", "period_end_date": "2021-12-31", "period_type": "fiscal_year", "pre_tax_profit": -13500000, "revenue": 36965000, "total_operating_expense": 18049000 }, { "cost_of_goods_sold": 11383000, "cost_of_goods_sold_currency": "€", "ebit": -8515000, "ebitda": -7581000, "ebitda_margin": null, "ebit_margin": null, "earnings_per_share": null, "gross_profit": 6261000, "gross_profit_margin": null, "income_tax_expense": 15000, "interest_expense": 1155000, "interest_income": 0, "net_income": 80031000, "period_display_end_date": "H1, 2022", "period_end_date": "2022-06-30", "period_type": "h1", "pre_tax_profit": 80046000, "revenue": 17644000, "total_operating_expense": 13842000 }, { "cost_of_goods_sold": 30259000, "cost_of_goods_sold_currency": "€", "ebit": -17728000, "ebitda": -15866000, "ebitda_margin": -0.37334400075299434, "ebit_margin": -0.4171588582723486, "earnings_per_share": null, "gross_profit": 12585000, "gross_profit_margin": 0.2961385509565381, "income_tax_expense": 604000, "interest_expense": 143000, "interest_income": 302000, "net_income": 35992000, "period_display_end_date": "FY, 2022", "period_end_date": "2022-12-31", "period_type": "fiscal_year", "pre_tax_profit": 36596000, "revenue": 42497000, "total_operating_expense": 28451000 }, { "cost_of_goods_sold": 25249000, "cost_of_goods_sold_currency": "€", "ebit": 6358000, "ebitda": 7262000, "ebitda_margin": 0.16584073625796433, "ebit_margin": 0.14519628217132158, "earnings_per_share": null, "gross_profit": 18554000, "gross_profit_margin": 0.4237137180570463, "income_tax_expense": 7259000, "interest_expense": 46000, "interest_income": 386000, "net_income": 1804000, "period_display_end_date": "H1, 2023", "period_end_date": "2023-06-30", "period_type": "h1", "pre_tax_profit": 9063000, "revenue": 43789000, "total_operating_expense": 11292000 }, { "cost_of_goods_sold": 53787000, "cost_of_goods_sold_currency": "€", "ebit": -369000, "ebitda": 1518000, "ebitda_margin": 0.019537685337726523, "ebit_margin": -0.00474927924217463, "earnings_per_share": null, "gross_profit": 23910000, "gross_profit_margin": 0.3077378500823723, "income_tax_expense": 3275000, "interest_expense": 34417000, "interest_income": 2816000, "net_income": 75795000, "period_display_end_date": "FY, 2023", "period_end_date": "2023-12-31", "period_type": "fiscal_year", "pre_tax_profit": 79070000, "revenue": 77696000, "total_operating_expense": 22392000 }, { "cost_of_goods_sold": 23906000, "cost_of_goods_sold_currency": "€", "ebit": -17983000, "ebitda": -16904000, "ebitda_margin": -0.6285650541032982, "ebit_margin": -0.6686870189268583, "earnings_per_share": null, "gross_profit": 2993000, "gross_profit_margin": 0.11129290149853122, "income_tax_expense": 2395000, "interest_expense": 5269000, "interest_income": 767000, "net_income": -10094000, "period_display_end_date": "H1, 2024", "period_end_date": "2024-06-30", "period_type": "h1", "pre_tax_profit": -7699000, "revenue": 26893000, "total_operating_expense": 19897000 } ], "stock_information": [ { "closing_price": 49.5, "currency": "€", "date": "2021-11-10", "marketcap": 535718688 }, { "closing_price": 65.0999984741211, "currency": "€", "date": "2023-07-28", "marketcap": 1044125824 }, { "closing_price": 40.849998474121094, "currency": "€", "date": "2024-04-30", "marketcap": 723049088 }, { "closing_price": 61, "currency": "€", "date": "2021-03-31", "marketcap": 671000000 }, { "closing_price": 75.30000305175781, "currency": "€", "date": "2022-08-31", "marketcap": 824327616 }, { "closing_price": 69.80000305175781, "currency": "€", "date": "2023-04-27", "marketcap": 1054594304 }, { "closing_price": 61.400001525878906, "currency": "€", "date": "2023-08-31", "marketcap": 991247744 }, { "closing_price": 73.9000015258789, "currency": "€", "date": "2022-05-31", "marketcap": 818795200 }, { "closing_price": 55.5, "currency": "€", "date": "2023-12-29", "marketcap": 900576320 }, { "closing_price": 64.30000305175781, "currency": "€", "date": "2022-04-27", "marketcap": 711466688 }, { "closing_price": 55.5, "currency": "€", "date": "2021-07-30", "marketcap": 600654272 }, { "closing_price": 44.70000076293945, "currency": "€", "date": "2024-05-31", "marketcap": 789263424 }, { "closing_price": 32.5, "currency": "€", "date": "2020-11-30", "marketcap": 368432992 }, { "closing_price": 65.4000015258789, "currency": "€", "date": "2023-11-30", "marketcap": 1049866240 }, { "closing_price": 51.099998474121094, "currency": "€", "date": "2024-06-28", "marketcap": 902267584 }, { "closing_price": 55.29999923706055, "currency": "€", "date": "2023-10-31", "marketcap": 887482048 }, { "closing_price": 53, "currency": "€", "date": "2024-08-30", "marketcap": 946590592 }, { "closing_price": 48.349998474121094, "currency": "€", "date": "2024-02-29", "marketcap": 853711104 }, { "closing_price": 61.900001525878906, "currency": "€", "date": "2023-06-30", "marketcap": 999276480 }, { "closing_price": 53.599998474121094, "currency": "€", "date": "2020-12-30", "marketcap": 589600000 }, { "closing_price": 85.80000305175781, "currency": "€", "date": "2022-12-30", "marketcap": 949359872 }, { "closing_price": 83.80000305175781, "currency": "€", "date": "2023-01-31", "marketcap": 927230272 }, { "closing_price": 62.29999923706055, "currency": "€", "date": "2021-06-30", "marketcap": 674248000 }, { "closing_price": 58.79999923706055, "currency": "€", "date": "2021-01-28", "marketcap": 646800000 }, { "closing_price": 63.900001525878906, "currency": "€", "date": "2021-04-30", "marketcap": 714561792 }, { "closing_price": 49.849998474121094, "currency": "€", "date": "2024-10-29", "marketcap": 880570304 }, { "closing_price": 70.9000015258789, "currency": "€", "date": "2022-09-30", "marketcap": 784494336 }, { "closing_price": 52.400001525878906, "currency": "€", "date": "2024-07-31", "marketcap": 925221568 }, { "closing_price": 82.5, "currency": "€", "date": "2022-11-30", "marketcap": 912846016 }, { "closing_price": 66.4000015258789, "currency": "€", "date": "2023-03-31", "marketcap": 1004937472 }, { "closing_price": 77.0999984741211, "currency": "€", "date": "2023-02-28", "marketcap": 1166877696 }, { "closing_price": 61.5, "currency": "€", "date": "2022-03-31", "marketcap": 680485184 }, { "closing_price": 46.099998474121094, "currency": "€", "date": "2022-02-28", "marketcap": 510087264 }, { "closing_price": 49.599998474121094, "currency": "€", "date": "2021-09-30", "marketcap": 536800928 }, { "closing_price": 49.599998474121094, "currency": "€", "date": "2022-01-31", "marketcap": 548814080 }, { "closing_price": 76.80000305175781, "currency": "€", "date": "2022-06-30", "marketcap": 849776704 }, { "closing_price": 45.849998474121094, "currency": "€", "date": "2024-03-28", "marketcap": 809568832 }, { "closing_price": 58.29999923706055, "currency": "€", "date": "2023-09-29", "marketcap": 945095488 }, { "closing_price": 84.4000015258789, "currency": "€", "date": "2022-07-29", "marketcap": 933869120 }, { "closing_price": 52.20000076293945, "currency": "€", "date": "2021-08-31", "marketcap": 564939712 }, { "closing_price": 66, "currency": "€", "date": "2021-02-26", "marketcap": 730243776 }, { "closing_price": 49.900001525878906, "currency": "€", "date": "2024-01-31", "marketcap": 810675456 }, { "closing_price": 62.900001525878906, "currency": "€", "date": "2021-05-28", "marketcap": 680741568 }, { "closing_price": 51.79999923706055, "currency": "€", "date": "2021-10-28", "marketcap": 560610688 }, { "closing_price": 78.69999694824219, "currency": "€", "date": "2023-05-25", "marketcap": 1190636544 }, { "closing_price": 54.900001525878906, "currency": "€", "date": "2024-09-30", "marketcap": 969363840 }, { "closing_price": 72.5999984741211, "currency": "€", "date": "2022-10-31", "marketcap": 803304448 } ], "last_funding_round_name": "Post-IPO Equity - Formycon", "last_funding_round_announced_date": "2024-01-29", "last_funding_round_lead_investors": [ "Richter Group" ], "last_funding_round_amount_raised": 89752563, "last_funding_round_amount_raised_currency": "$", "last_funding_round_num_investors": 1, "funding_rounds": [ { "name": "Grant - Formycon", "announced_date": "2020-10-13", "lead_investors": [ "********" ], "amount_raised": 340547, "amount_raised_currency": "$", "num_investors": 1 }, { "name": "Post-IPO Equity - Formycon", "announced_date": "2024-01-29", "lead_investors": [ "********" ], "amount_raised": 89837828, "amount_raised_currency": "$", "num_investors": 1 }, { "name": "Post-IPO Equity - Formycon", "announced_date": "2024-01-29", "lead_investors": [ "********" ], "amount_raised": 89752563, "amount_raised_currency": "$", "num_investors": 1 } ], "ownership_status": "Public", "parent_company_information": null, "acquired_by_summary": null, "num_acquisitions_source_1": null, "acquisition_list_source_1": [], "num_acquisitions_source_2": null, "acquisition_list_source_2": [], "num_acquisitions_source_5": null, "acquisition_list_source_5": [], "competitors": [ { "company_name": "divis laboratories", "similarity_score": null }, { "company_name": "sun pharma", "similarity_score": null }, { "company_name": "teva", "similarity_score": null }, { "company_name": "torrent pharmaceuticals", "similarity_score": null } ], "competitors_websites": [ { "website": "gabionline.net", "similarity_score": 100, "total_website_visits_monthly": 17400, "category": "Health > Biotechnology and Pharmaceuticals", "rank_category": 2463 }, { "website": "contractpharma.com", "similarity_score": 87, "total_website_visits_monthly": 80300, "category": "Health > Biotechnology and Pharmaceuticals", "rank_category": 589 } ], "company_phone_numbers": [ "********" ], "company_emails": [], "pricing_available": null, "free_trial_available": null, "demo_available": null, "is_downloadable": null, "mobile_apps_exist": null, "online_reviews_exist": null, "documentation_exist": null, "product_reviews_count": null, "product_reviews_aggregate_score": null, "product_reviews_score_distribution": null, "product_pricing_summary": [], "num_news_articles": 0, "news_articles": [], "num_technologies_used": 16, "technologies_used": [ { "technology": "python", "first_verified_at": "2024-07-15", "last_verified_at": "2025-01-06" }, { "technology": "box", "first_verified_at": "2024-11-13", "last_verified_at": "2025-03-31" }, { "technology": "amp", "first_verified_at": "2024-06-10", "last_verified_at": "2025-03-31" }, { "technology": "microsoft", "first_verified_at": "2024-04-04", "last_verified_at": "2025-03-31" }, { "technology": "c", "first_verified_at": "2024-07-15", "last_verified_at": "2025-01-06" }, { "technology": "impact", "first_verified_at": "2024-07-01", "last_verified_at": "2024-12-23" }, { "technology": "linux", "first_verified_at": "2024-04-04", "last_verified_at": "2024-08-05" }, { "technology": "sparked", "first_verified_at": "2024-04-04", "last_verified_at": "2025-03-31" }, { "technology": "well", "first_verified_at": "2024-04-04", "last_verified_at": "2025-03-31" }, { "technology": "adobe", "first_verified_at": "2024-07-15", "last_verified_at": "2025-01-06" }, { "technology": "microsoft office", "first_verified_at": "2025-02-18", "last_verified_at": "2025-03-31" }, { "technology": "mix", "first_verified_at": "2024-04-04", "last_verified_at": "2024-09-16" }, { "technology": "iam", "first_verified_at": "2024-04-04", "last_verified_at": "2024-09-02" }, { "technology": "operative", "first_verified_at": "2024-04-04", "last_verified_at": "2024-12-16" }, { "technology": "microsoft dynamics 365", "first_verified_at": "2025-02-18", "last_verified_at": "2025-03-31" }, { "technology": "wordpress", "first_verified_at": "2024-07-15", "last_verified_at": "2025-01-06" } ], "total_website_visits_monthly": 17100, "visits_change_monthly": 15.13, "rank_global": 1241796, "rank_country": 156295, "rank_category": 172, "visits_breakdown_by_country": [], "visits_breakdown_by_gender": { "male_percentage": 0, "female_percentage": 0 }, "visits_breakdown_by_age": { "age_18_24_percentage": 0, "age_25_34_percentage": 0, "age_35_44_percentage": 0, "age_45_54_percentage": 0, "age_55_64_percentage": 0, "age_65_plus_percentage": 0 }, "bounce_rate": 33.94, "pages_per_visit": 2.97, "average_visit_duration_seconds": 191, "similarly_ranked_websites": [ "careers.pfizer.com", "deutscher-apotheker-service.de", "formycon.com", "astrazeneca.de", "tad.de", "contractpharma.com", "gabionline.net", "formycon.com" ], "top_topics": [], "company_employee_reviews_count": 7, "company_employee_reviews_aggregate_score": 4, "employee_reviews_score_breakdown": { "business_outlook": 1, "career_opportunities": 3.8, "ceo_approval": -1, "compensation_benefits": 4.1, "culture_values": 4.5, "diversity_inclusion": 4.6, "recommend": 1, "senior_management": 4.2, "work_life_balance": 4.2 }, "employee_reviews_score_distribution": { "1": 0, "2": 0, "3": 0, "4": 2, "5": 1 }, "active_job_postings_count": 2, "active_job_postings_titles": [ "(Senior) Compliance and Data Protection Counsel (gn)", "Bilanzbuchhalter (gn) in Voll- oder Teilzeit" ], "base_salary": [], "additional_pay": [], "total_salary": [], "employees_count_breakdown_by_seniority": { "employees_count_owner": 0, "employees_count_founder": 0, "employees_count_clevel": 2, "employees_count_partner": 1, "employees_count_vp": 4, "employees_count_head": 5, "employees_count_director": 10, "employees_count_manager": 16, "employees_count_senior": 28, "employees_count_intern": 0, "employees_count_specialist": 40, "employees_count_other_management": 27 }, "employees_count_breakdown_by_department": { "employees_count_medical": 4, "employees_count_sales": 1, "employees_count_hr": 3, "employees_count_legal": 12, "employees_count_marketing": 1, "employees_count_finance": 4, "employees_count_technical": 6, "employees_count_consulting": 1, "employees_count_operations": 9, "employees_count_product": 4, "employees_count_general_management": 4, "employees_count_administrative": 0, "employees_count_customer_service": 0, "employees_count_project_management": 10, "employees_count_design": 0, "employees_count_research": 37, "employees_count_trades": 0, "employees_count_real_estate": 0, "employees_count_education": 2, "employees_count_other_department": 35 }, "employees_count_breakdown_by_region": { "employees_count_eastern_europe": 0, "employees_count_latin_america": 0, "employees_count_southern_europe": 2, "employees_count_sub_saharan_africa": 0, "employees_count_central_asia": 0, "employees_count_northern_america": 0, "employees_count_australia_new_zealand": 0, "employees_count_northern_europe": 0, "employees_count_south_eastern_asia": 0, "employees_count_polynesia": 0, "employees_count_southern_asia": 0, "employees_count_northern_africa": 0, "employees_count_melanesia": 0, "employees_count_western_europe": 131, "employees_count_western_asia": 0, "employees_count_eastern_asia": 0, "employees_count_micronesia": 0, "employees_count_unknown": 0 }, "employees_count_by_country": [ { "country": "Germany", "employee_count": 131 }, { "country": "Croatia", "employee_count": 1 }, { "country": "Italy", "employee_count": 1 } ], "key_executives": [ { "member_id": 752128655, "member_full_name": "*******", "member_position_title": "Associate Director Procurement" }, { "member_id": 169407321, "member_full_name": "*******", "member_position_title": "Head Of Qualitymanagement" }, { "member_id": 125959076, "member_full_name": "*******", "member_position_title": "Program Head" }, { "member_id": 288908510, "member_full_name": "*******", "member_position_title": "Chief Financial Officer" }, { "member_id": 19787771, "member_full_name": "*******", "member_position_title": "Head Of Quality Management Laboratories" }, { "member_id": 461014390, "member_full_name": "*******", "member_position_title": "Principal Scientist Drug Product IP New Formulations Technologies" }, { "member_id": 190318391, "member_full_name": "*******", "member_position_title": "Head Of Process Science I" }, { "member_id": 53078655, "member_full_name": "*******", "member_position_title": "Associate Director Regulatory Affairs CMC" }, { "member_id": 175899416, "member_full_name": "*******", "member_position_title": "Vorstand CEO" }, { "member_id": 261448302, "member_full_name": "*******", "member_position_title": "Senior Director, Procurement" }, { "member_id": 185234124, "member_full_name": "*******", "member_position_title": "Sr. Director Drug Product" }, { "member_id": 154884108, "member_full_name": "*******", "member_position_title": "Head Of Project Analytics" }, { "member_id": 164278565, "member_full_name": "*******", "member_position_title": "Director Business Development Strategy" }, { "member_id": 194845519, "member_full_name": "*******", "member_position_title": "Head Of Preclinical Development" }, { "member_id": 97271382, "member_full_name": "*******", "member_position_title": "Senior Director IP Litigation" }, { "member_id": 456134217, "member_full_name": "*******", "member_position_title": "Director Investor Relations Corporate Communications" }, { "member_id": 338935002, "member_full_name": "*******", "member_position_title": "Associate Director Of Clinical Pharmacology" }, { "member_id": 84982082, "member_full_name": "*******", "member_position_title": "Principal Scientist Process Sciences" }, { "member_id": 458937832, "member_full_name": "*******", "member_position_title": "Chief Scientific Officer" }, { "member_id": 670827095, "member_full_name": "*******", "member_position_title": "Head Of Process Sciences" }, { "member_id": 347005672, "member_full_name": "*******", "member_position_title": "Senior Director Finance" }, { "member_id": 585664696, "member_full_name": "*******", "member_position_title": "Vorstand" }, { "member_id": 752103339, "member_full_name": "*******", "member_position_title": "Director Clinical Operations" }, { "member_id": 447314607, "member_full_name": "*******", "member_position_title": "Associate Director Protein Analytics" }, { "member_id": 488244305, "member_full_name": "*******", "member_position_title": "Director Human Resources" }, { "member_id": 650106179, "member_full_name": "*******", "member_position_title": "IT Business Partner" }, { "member_id": 58047246, "member_full_name": "*******", "member_position_title": "Senior Director Regulatory Affairs" } ], "key_employee_change_events": [ { "employee_change_event_name": "*******", "employee_change_event_date": "2024-11-11", "employee_change_event_url": null } ], "key_executive_arrivals": [], "key_executive_departures": [], "employees_count_change": { "current": 192, "change_monthly": 1, "change_monthly_percentage": 0.5235602094240838, "change_quarterly": 4, "change_quarterly_percentage": 2.127659574468085, "change_yearly": 18, "change_yearly_percentage": 10.344827586206897 }, "employees_count_by_month": [ { "employees_count": 161, "date": "2023-10" }, { "employees_count": 69, "date": "2020-07" }, { "employees_count": 69, "date": "2020-01" }, { "employees_count": 188, "date": "2025-01" }, { "employees_count": 148, "date": "2023-05" }, { "employees_count": 156, "date": "2023-06" }, { "employees_count": 0, "date": "2020-11" }, { "employees_count": 178, "date": "2024-08" }, { "employees_count": 171, "date": "2024-02" }, { "employees_count": 82, "date": "2021-02" }, { "employees_count": 182, "date": "2024-10" }, { "employees_count": 52, "date": "2019-05" }, { "employees_count": 109, "date": "2021-11" }, { "employees_count": 75, "date": "2020-10" }, { "employees_count": 122, "date": "2022-08" }, { "employees_count": 175, "date": "2024-05" }, { "employees_count": 75, "date": "2020-12" }, { "employees_count": 127, "date": "2022-10" }, { "employees_count": 53, "date": "2019-02" }, { "employees_count": 144, "date": "2023-03" }, { "employees_count": 168, "date": "2024-01" }, { "employees_count": 161, "date": "2023-11" }, { "employees_count": 64, "date": "2019-10" }, { "employees_count": 64, "date": "2019-09" }, { "employees_count": 142, "date": "2023-02" }, { "employees_count": 99, "date": "2021-07" }, { "employees_count": 134, "date": "2022-12" }, { "employees_count": 67, "date": "2020-02" }, { "employees_count": 71, "date": "2020-08" }, { "employees_count": 161, "date": "2023-12" }, { "employees_count": 68, "date": "2020-05" }, { "employees_count": 176, "date": "2024-07" }, { "employees_count": 191, "date": "2025-03" }, { "employees_count": 192, "date": "2025-04" }, { "employees_count": 146, "date": "2023-04" }, { "employees_count": 52, "date": "2019-04" }, { "employees_count": 104, "date": "2021-09" }, { "employees_count": 112, "date": "2021-12" }, { "employees_count": 159, "date": "2023-07" }, { "employees_count": 113, "date": "2022-02" }, { "employees_count": 75, "date": "2021-01" }, { "employees_count": 122, "date": "2022-09" }, { "employees_count": 190, "date": "2025-02" }, { "employees_count": 186, "date": "2024-12" }, { "employees_count": 117, "date": "2022-05" }, { "employees_count": 116, "date": "2022-07" }, { "employees_count": 62, "date": "2019-07" }, { "employees_count": 101, "date": "2021-08" }, { "employees_count": 180, "date": "2024-11" }, { "employees_count": 111, "date": "2022-01" }, { "employees_count": 64, "date": "2019-08" }, { "employees_count": 67, "date": "2019-11" }, { "employees_count": 161, "date": "2023-08" }, { "employees_count": 68, "date": "2020-04" }, { "employees_count": 161, "date": "2023-09" }, { "employees_count": 53, "date": "2019-01" }, { "employees_count": 69, "date": "2020-06" }, { "employees_count": 114, "date": "2022-04" }, { "employees_count": 68, "date": "2020-03" }, { "employees_count": 107, "date": "2021-10" }, { "employees_count": 116, "date": "2022-06" }, { "employees_count": 60, "date": "2019-06" }, { "employees_count": 86, "date": "2021-03" }, { "employees_count": 138, "date": "2023-01" }, { "employees_count": 178, "date": "2024-06" }, { "employees_count": 113, "date": "2022-03" }, { "employees_count": 71, "date": "2020-09" }, { "employees_count": 172, "date": "2024-03" }, { "employees_count": 181, "date": "2024-09" }, { "employees_count": 130, "date": "2022-11" }, { "employees_count": 90, "date": "2021-06" }, { "employees_count": 69, "date": "2019-12" }, { "employees_count": 53, "date": "2019-03" }, { "employees_count": 87, "date": "2021-04" }, { "employees_count": 89, "date": "2021-05" }, { "employees_count": 174, "date": "2024-04" } ], "professional_network_followers_count_change": { "current": 7789, "change_monthly": 128, "change_monthly_percentage": 1.6708001566375148, "change_quarterly": 599, "change_quarterly_percentage": 8.331015299026426, "change_yearly": 2048, "change_yearly_percentage": 35.673227660686294 }, "professional_network_followers_count_by_month": [ { "follower_count": 4521, "date": "2023-11" }, { "follower_count": 4521, "date": "2023-10" }, { "follower_count": 515, "date": "2019-09" }, { "follower_count": 995, "date": "2020-07" }, { "follower_count": 696, "date": "2020-01" }, { "follower_count": 7190, "date": "2025-01" }, { "follower_count": 4180, "date": "2023-05" }, { "follower_count": 4295, "date": "2023-06" }, { "follower_count": 1205, "date": "2020-11" }, { "follower_count": 6412, "date": "2024-08" }, { "follower_count": 5305, "date": "2024-02" }, { "follower_count": 1550, "date": "2021-02" }, { "follower_count": 4421, "date": "2023-07" }, { "follower_count": 6581, "date": "2024-09" }, { "follower_count": 2503, "date": "2022-02" }, { "follower_count": 1347, "date": "2021-01" }, { "follower_count": 3170, "date": "2022-09" }, { "follower_count": 3557, "date": "2022-11" }, { "follower_count": 2449, "date": "2022-01" }, { "follower_count": 1856, "date": "2021-06" }, { "follower_count": 6064, "date": "2024-06" }, { "follower_count": 1124, "date": "2020-09" }, { "follower_count": 672, "date": "2019-12" }, { "follower_count": 2580, "date": "2022-03" }, { "follower_count": 515, "date": "2019-10" }, { "follower_count": 1812, "date": "2021-05" }, { "follower_count": 4521, "date": "2023-12" }, { "follower_count": 891, "date": "2020-05" }, { "follower_count": 6208, "date": "2024-07" }, { "follower_count": 7404, "date": "2025-02" }, { "follower_count": 5801, "date": "2024-05" }, { "follower_count": 5202, "date": "2024-01" }, { "follower_count": 358, "date": "2019-02" }, { "follower_count": 3961, "date": "2023-03" }, { "follower_count": 7146, "date": "2024-12" }, { "follower_count": 2687, "date": "2022-05" }, { "follower_count": 4521, "date": "2023-09" }, { "follower_count": 358, "date": "2019-01" }, { "follower_count": 990, "date": "2020-06" }, { "follower_count": 2612, "date": "2022-04" }, { "follower_count": 807, "date": "2020-03" }, { "follower_count": 2293, "date": "2021-10" }, { "follower_count": 2833, "date": "2022-06" }, { "follower_count": 456, "date": "2019-06" }, { "follower_count": 1600, "date": "2021-03" }, { "follower_count": 3679, "date": "2023-01" }, { "follower_count": 358, "date": "2019-03" }, { "follower_count": 7661, "date": "2025-03" }, { "follower_count": 398, "date": "2019-05" }, { "follower_count": 2319, "date": "2021-11" }, { "follower_count": 1153, "date": "2020-10" }, { "follower_count": 3170, "date": "2022-08" }, { "follower_count": 1277, "date": "2020-12" }, { "follower_count": 3440, "date": "2022-10" }, { "follower_count": 6694, "date": "2024-10" }, { "follower_count": 1776, "date": "2021-04" }, { "follower_count": 5741, "date": "2024-04" }, { "follower_count": 5533, "date": "2024-03" }, { "follower_count": 7789, "date": "2025-04" }, { "follower_count": 4055, "date": "2023-04" }, { "follower_count": 398, "date": "2019-04" }, { "follower_count": 2240, "date": "2021-09" }, { "follower_count": 2412, "date": "2021-12" }, { "follower_count": 515, "date": "2019-08" }, { "follower_count": 576, "date": "2019-11" }, { "follower_count": 4521, "date": "2023-08" }, { "follower_count": 874, "date": "2020-04" }, { "follower_count": 1995, "date": "2021-07" }, { "follower_count": 3621, "date": "2022-12" }, { "follower_count": 774, "date": "2020-02" }, { "follower_count": 3808, "date": "2023-02" }, { "follower_count": 1073, "date": "2020-08" }, { "follower_count": 3011, "date": "2022-07" }, { "follower_count": 475, "date": "2019-07" }, { "follower_count": 2135, "date": "2021-08" }, { "follower_count": 6866, "date": "2024-11" } ], "active_job_postings_count_change": { "current": 2, "change_monthly": -2, "change_monthly_percentage": -50, "change_quarterly": -4, "change_quarterly_percentage": -66.66666666666666, "change_yearly": -8, "change_yearly_percentage": -80 }, "product_reviews_score_change": null, "product_reviews_score_by_month": [], "total_website_visits_change": { "current": 17100, "change_monthly": 2200, "change_monthly_percentage": 14.76510067114094, "change_quarterly": 9500, "change_quarterly_percentage": 125, "change_yearly": 4400, "change_yearly_percentage": 34.645669291338585 }, "total_website_visits_by_month": [ { "total_website_visits": 7600, "date": "2025-01" }, { "total_website_visits": 14900, "date": "2025-03" }, { "total_website_visits": 7600, "date": "2025-02" }, { "total_website_visits": 12700, "date": "2024-05" }, { "total_website_visits": 12700, "date": "2024-04" }, { "total_website_visits": 17100, "date": "2025-04" }, { "total_website_visits": 3700, "date": "2024-10" }, { "total_website_visits": 12700, "date": "2024-08" }, { "total_website_visits": 4900, "date": "2024-11" }, { "total_website_visits": 12700, "date": "2024-07" }, { "total_website_visits": 4900, "date": "2024-12" }, { "total_website_visits": 12700, "date": "2024-09" }, { "total_website_visits": 12700, "date": "2024-06" } ], "employee_reviews_score_aggregated_change": { "current": 4, "change_monthly": 0, "change_quarterly": null, "change_yearly": null }, "employee_reviews_score_aggregated_by_month": [ { "aggregated_score": 4, "date": "2025-03" }, { "aggregated_score": 4, "date": "2025-04" } ], "employee_reviews_score_business_outlook_change": { "current": 1, "change_monthly": 0, "change_quarterly": null, "change_yearly": null }, "employee_reviews_score_business_outlook_by_month": [ { "business_outlook_score": 1, "date": "2025-04" }, { "business_outlook_score": 1, "date": "2025-03" } ], "employee_reviews_score_career_opportunities_change": { "current": 3.8, "change_monthly": 0, "change_quarterly": null, "change_yearly": null }, "employee_reviews_score_career_opportunities_by_month": [ { "career_opportunities_score": 3.8, "date": "2025-04" }, { "career_opportunities_score": 3.8, "date": "2025-03" } ], "employee_reviews_score_ceo_approval_change": { "current": -1, "change_monthly": 0, "change_quarterly": null, "change_yearly": null }, "employee_reviews_score_ceo_approval_by_month": [ { "ceo_approval_score": -1, "date": "2025-03" }, { "ceo_approval_score": -1, "date": "2025-04" } ], "employee_reviews_score_compensation_benefits_change": { "current": 4.1, "change_monthly": 0, "change_quarterly": null, "change_yearly": null }, "employee_reviews_score_compensation_benefits_by_month": [ { "compensation_benefits_score": 4.1, "date": "2025-04" }, { "compensation_benefits_score": 4.1, "date": "2025-03" } ], "employee_reviews_score_culture_values_change": { "current": 4.5, "change_monthly": 0, "change_quarterly": null, "change_yearly": null }, "employee_reviews_score_culture_values_by_month": [ { "culture_values_score": 4.5, "date": "2025-04" }, { "culture_values_score": 4.5, "date": "2025-03" } ], "employee_reviews_score_diversity_inclusion_change": { "current": 4.6, "change_monthly": 0, "change_quarterly": null, "change_yearly": null }, "employee_reviews_score_diversity_inclusion_by_month": [ { "diversity_inclusion_score": 4.6, "date": "2025-04" }, { "diversity_inclusion_score": 4.6, "date": "2025-03" } ], "employee_reviews_score_recommend_change": { "current": 1, "change_monthly": 0, "change_quarterly": null, "change_yearly": null }, "employee_reviews_score_recommend_by_month": [ { "recommend_score": 1, "date": "2025-04" }, { "recommend_score": 1, "date": "2025-03" } ], "employee_reviews_score_senior_management_change": { "current": 4.2, "change_monthly": 0, "change_quarterly": null, "change_yearly": null }, "employee_reviews_score_senior_management_by_month": [ { "senior_management_score": 4.2, "date": "2025-03" }, { "senior_management_score": 4.2, "date": "2025-04" } ], "employee_reviews_score_work_life_balance_change": { "current": 4.2, "change_monthly": 0, "change_quarterly": null, "change_yearly": null }, "employee_reviews_score_work_life_balance_by_month": [ { "work_life_balance_score": 4.2, "date": "2025-03" }, { "work_life_balance_score": 4.2, "date": "2025-04" } ], "expired_domain": 0, "unique_domain": 1, "unique_website": 1, "last_updated_at": "2025-04-03", "created_at": "2016-06-25", "industry_group_1": "Biotech", "industry_group_2": null }
Your data must have high quality if you want to turn it into valuable insights. Arm yourself with the latest intel that will paint the big picture about emerging Biotech industry trends and tell you granular, company-level stories.
Each Belarus Biotech company profile, collected and enriched by Coresignal, includes:
Combined, these data points create the most comprehensive Biotech companies in Belarus database. With 500+ data points for analysis, you can be sure to find the answer to any question about the industry.
Access data as comprehensive dataset files or via an API
Boost your existing dataset with the no-code data enrichment tool
Find competitors and similar companies
Track headcount changes
Review Belarus historical company data
200 free collect and 400 search credits
Unlock the Belarus Biotech sector with Coresignal's extensive datasets and data APIs
With over 15 company profiles, you can easily access detailed information to analyze the market, conduct competitive analysis, and qualify sales leads.
You can purchase our data directly through our self-service platform, or integrate it seamlessly into your systems via data APIs. Whether you need a one-time dataset or continuous access, Coresignal offers flexible solutions to meet your needs.
Coresignal is a public web data vendor that delivers fresh data about companies, professionals, and jobs for 500+ leading companies in market research, venture capital investment, HR tech, sales, and marketing industries. Founded in 2016, the company is known for its high-quality, fresh data and professional service. Coresignal is a member of the Ethical Web Data Collection Initiative and supports academic institutions with data for research.
in the market
clients
data records